Antares Pharma, Inc. (ATRS)

Income Before Tax

$54.75M

TTM · Period ending: · USD

ATRS logo

ATRS Income Before Tax

Latest reported$54.75M
ATRS TTM Pre-Tax Income ($0.00 → $54.75M)
High-resolution chart · PNG

ATRS income before tax history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Antares Pharma, Inc. Income Before Tax — Trailing twelve months (TTM) (USD)
Period endingIncome Before Tax (USD)
54,750,000
62,271,000
22,273,000
20,048,000
16,660,000
9,921,000
9,510,000
5,557,000
1,156,000
-2,027,000
-588,000
-3,567,000
-5,861,000
-6,515,000
-16,363,618
-19,880,139
-18,200,083
-16,743,000
-17,428,630
-18,097,092
-21,318,611
-24,238,804
-26,290,041
-25,907,099
-21,352,282
-20,483,846
-24,080,305
-25,528,705
-33,119,784
-35,126,715
-31,013,886
-30,187,402
-26,192,933
-20,806,776
-19,883,406
-17,057,688
-14,761,504
-11,427,450
-6,624,341
-4,389,361
-3,136,386
-4,442,625
-5,540,894
-5,884,523
-5,889,205
-6,117,515
-7,214,995
-8,196,735
-8,733,395
-9,861,159
-10,044,183
-10,464,247
-11,504,679
-12,221,839
-12,940,728
-12,588,056
-11,671,293
-8,678,616
-6,880,791
-6,217,300
-6,566,148
-8,449,949
-8,882,381
-8,859,264
-8,641,451
-8,592,260
-9,236,118
-9,462,755
-8,835,176
-8,349,648
-8,527,251
-29,287,837
-31,013,796
-31,869,395
-32,798,763
-13,658,481
-12,088,676
-11,569,445
-10,885,226
-9,189,763
-8,989,768
-8,459,455
-5,451,940
-3,295,050
-1,616,327
0
0
0
0
0
0
-1,300,000
-2,300,000
-3,200,000
-3,200,000
-2,900,000
-2,700,000
-1,800,000
-1,800,000
-800,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.